Shanghai Epimab Biotherapeutics Co., Ltd.

This study tests a new drug called EMB-01 in 54 adults with advanced colorectal cancer that has come back or spread. Participants are randomly assigned to receive the drug once weekly or once weekly for 6 weeks then every two weeks. The goal is to see which schedule works better …